Characteristics of the DRPs and PIs
| Characteristics | Total (n=1569) | Accepted (n=1449) |
| n (%) | n (%) | |
| DRP | ||
| Subtherapeutic dosage | 322 (20.5) | 284 (19.6) |
| Untreated indication | 308 (19.6) | 266 (18.4) |
| Supratherapeutic dosage | 299 (19.1) | 291 (20.1) |
| Adverse drug reaction | 155 (9.9) | 145 (10.0) |
| Drug without indication | 148 (9.4) | 132 (9.1) |
| Drug–drug interaction | 132 (8.4) | 130 (9.0) |
| Drug monitoring | 85 (5.4) | 83 (5.7) |
| Improper administration | 42 (2.7) | 42 (2.9) |
| Non conformity to guidelines/contraindication | 41 (2.6) | 40 (2.7) |
| Failure to receive drug | 37 (2.4) | 36 (2.5) |
| PI | ||
| Dose adjustment | 687 (43.8) | 635 (43.8) |
| Addition of a new drug | 351 (22.4) | 309 (21.3) |
| Drug discontinuation | 210 (13.4) | 191 (13.2) |
| Drug monitoring | 180 (11.5) | 175 (12.1) |
| Drug switch | 102 (6.5) | 100 (6.9) |
| Administration mode optimisation | 37 (2.3) | 37 (2.6) |
| Change of administration route | 2 (0.1) | 2 (0.1) |
DRPs, drug-related problems; PIs, pharmacists’ interventions.